What is the current valuation of the US spinal cord-stimulator market as of 2024?

The market valuation was $977.55 Million in 2024. Read More

What is the projected market valuation for the US spinal cord-stimulator market in 2035?

The projected valuation for 2035 is $1800.0 Million. Read More

What is the expected CAGR for the US spinal cord-stimulator market during the forecast period 2025 - 2035?

The expected CAGR during this period is 5.71%. Read More

Which companies are the key players in the US spinal cord-stimulator market?

Key players include Medtronic, Boston Scientific, Abbott, Nevro, Stimwave, Stryker, Nuvectra, and Horizon Therapeutics. Read More

What are the main segments of the US spinal cord-stimulator market?

The main segments include Type, Application, End User, and Technology. Read More

What was the market size for implantable spinal cord stimulators in 2024?

The market size for implantable spinal cord stimulators was between $400.0 Million and $800.0 Million in 2024. Read More

How much revenue did chronic pain management applications generate in 2024?

Chronic pain management applications generated between $400.0 Million and $700.0 Million in 2024. Read More

What is the revenue range for hospitals as end users in the spinal cord-stimulator market?

Hospitals generated revenue between $300.0 Million and $550.0 Million in 2024. Read More

What are the revenue projections for burst spinal cord stimulators by 2035?

Revenue for burst spinal cord stimulators is projected to reach between $300.0 Million and $600.0 Million by 2035. Read More

What was the revenue range for non-rechargeable spinal cord stimulators in 2024?

The revenue range for non-rechargeable spinal cord stimulators was between $177.55 Million and $320.0 Million in 2024. Read More

US Spinal Cord Stimulator Market

ID: MRFR/HC/13096-HCR

100 Pages

Vikita Thakur

Last Updated: May 13, 2026

US Spinal Cord Stimulator Market Research Report: By Product Type (Traditional Spinal Cord Stimulators, Rechargeable Spinal Cord Stimulators, Non-Rechargeable Spinal Cord Stimulators), By Application (Chronic Pain Management, Neuropathic Pain Management, Failed Back Surgery Syndrome), By End User (Hospitals, Ambulatory Surgical Centers, Pain Clinics) and By Technology (Closed Loop Systems, Open Loop Systems, Wireless Systems) - Growth & Industry Forecast 2025 To 2035

US Spinal Cord Stimulator Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Life Sciences, BY Type (USD Million) | |
  1. 4.1.1 Non-Implantable | |
  2. 4.1.2 Implantable | |
  3. 4.1.3 Rechargeable | |
  4. 4.1.4 Non-Rechargeable |
2. 4.2 Life Sciences, BY Application (USD Million) | |
  1. 4.2.1 Chronic Pain Management | |
  2. 4.2.2 Neuropathic Pain | |
  3. 4.2.3 Decompression Syndrome | |
  4. 4.2.4 Failed Back Surgery Syndrome |
3. 4.3 Life Sciences, BY End User (USD Million) | |
  1. 4.3.1 Hospitals | |
  2. 4.3.2 Ambulatory Surgical Centers | |
  3. 4.3.3 Pain Management Clinics | |
  4. 4.3.4 Home Care Settings |
4. 4.4 Life Sciences, BY Technology (USD Million) | |
  1. 4.4.1 Conventional Spinal Cord Stimulators | |
  2. 4.4.2 Burst Spinal Cord Stimulators | |
  3. 4.4.3 High-Frequency Spinal Cord Stimulators 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Life Sciences | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Medtronic (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Boston Scientific (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Abbott (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Nevro (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Stimwave (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Stryker (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Nuvectra (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Horizon Therapeutics (IE) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 US MARKET ANALYSIS BY TYPE |
6. 6.3 US MARKET ANALYSIS BY APPLICATION |
7. 6.4 US MARKET ANALYSIS BY END USER |
8. 6.5 US MARKET ANALYSIS BY TECHNOLOGY |
9. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF LIFE SCIENCES |
12. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES |
14. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES |
15. 6.12 LIFE SCIENCES, BY TYPE, 2024 (% SHARE) |
16. 6.13 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million) |
17. 6.14 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE) |
18. 6.15 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million) |
19. 6.16 LIFE SCIENCES, BY END USER, 2024 (% SHARE) |
20. 6.17 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million) |
21. 6.18 LIFE SCIENCES, BY TECHNOLOGY, 2024 (% SHARE) |
22. 6.19 LIFE SCIENCES, BY TECHNOLOGY, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million) | |
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million) | |
  3. 7.2.3 BY END USER, 2025-2035 (USD Million) | |
  4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

US Life Sciences Market Segmentation

Life Sciences By Type (USD Million, 2025-2035)

Non-Implantable
Implantable
Rechargeable
Non-Rechargeable

Life Sciences By Application (USD Million, 2025-2035)

Chronic Pain Management
Neuropathic Pain
Decompression Syndrome
Failed Back Surgery Syndrome

Life Sciences By End User (USD Million, 2025-2035)

Hospitals
Ambulatory Surgical Centers
Pain Management Clinics
Home Care Settings

Life Sciences By Technology (USD Million, 2025-2035)

Conventional Spinal Cord Stimulators
Burst Spinal Cord Stimulators
High-Frequency Spinal Cord Stimulators

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”